Inhaled corticosteroids

Thematic Poster Session
Chairs: H. Magnussen (Grosshansdorf, Germany), K. Larsson (Solna, Sweden)

In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cells M. Stoeck, A. Hatzelmann, M. G. Belvisi, M. L. Foster, D. S. Bundschuh (Konstanz, Germany; Dagenham, Essex, United Kingdom)
Repeated inhalation of the new topical steroid ciclesonide does not lead to suppression of endogenous cortisol release in healthy subjects A. Drollmann, A. Weinbrenner, D. Hüneke, M. Ziesche, G. Engel, T. Bethke, V. Steinijans, W. Wurst, W. Siegmund (Konstanz, Greifswald, Germany)
Ciclesonide is effective in the treatment of bronchial asthma A. Drollmann, C. Langdon, R. Engelstätter, F. Rathgeb, V. W. Steinijans, W. Wurst (Konstanz, Germany; Holyport, United Kingdom)
Preclinical in vivo assessment of ciclesonide, a novel corticosteroid for the treatment of asthma M. G. Belvisi, D. S. Bundschuh, M. Stoeck, S. Wicks, S. Underwood, C. H. Battram, S. E. Webber, E. B. Haddad, M. L. Foster (Dagenham, United Kingdom; Konstanz, Germany)
Fluticasone propionate is as potent but more receptor-selective than mometasone furoate S. N. Farrow, I. J. Uings, R. Austin, M. Johnson (Stevenage, United Kingdom)
The pharmacokinetics of mometasone furoate administered by dry powder inhaler following single and multiple dosing in patients with mild-to-moderate persistent asthma M. B. Affrime, T. Kosoglou (Kenilworth, United States Of America)
Mometasone furoate 400 μg once daily is more efficacious than budesonide 400 μg once daily in improving asthma symptoms in patients with moderate persistent asthma J. Corren, R. B. Berkowitz, J. J. Murray, B. Prenner, K. B. Nolop (Los Angeles, Marrietta, Nashville, San Diego, Kenilworth, United States Of America)
A superior improvement in lung function in patients with moderate persistent asthma is seen with mometasone furoate 200 μg b.i.d delivered by dry powder inhaler compared with beclomethasone dipropionate 168 μg D. I. Bernstein, G. Rachelefsky, P. Chervinsky, R. A. Nathan, K. B. Nolop, J. E. Harrison (Cincinnati, Los Angeles, North Dartmouth, Colorado Springs, Kenilworth, United States Of America)
Efficacy of mometasone furoate in patients with mild-to-moderate asthma: lack of gender-specific effects J. P. Kemp, A. S. Nayak, D. I. Bernstein, G. Rachelefsky, J. E. Harrison, K. B. Nolop (San Diego, Normal, Cincinnati, Los Angeles, Kenilworth, United States Of America)
Low-dose (100 μg, b.i.d.) inhaled fluticasone propionate (FP) is as effective as high-dose (500 μg, b.i.d.) in mild symptomatic asthma A. Foresi, A. Pelucchi, S. Dorini, B. Mastropasqua, A. Chetta, R. D'Ippolito, A. Castagnaro, R. Testi, D. Olivieri (Sesto S. Giovanni, Parma, Verona, Italy)
Inhaled budesonide 800 μg once daily versus 400 μg twice daily in patients with mild-to-moderate asthma S. M. Lang, A. Bergner, N. Liebrich, D. F. Stratakis, R. M. Huber (Munich, Germany)
Comparative study of 8-weeks treatment of asthma exacerbations in adults with high doses of budesonide versus fluticasone I. V. Gogunskaya (Melitopol, Ukraine)
The efficacy and safety of fluticasone propionate on Chinese asthmatics J. Zheng, N. Zhong, J. Lin, X. Zhou, G. Qian (Guangzhou, Beijing, Shanghai, Chongqing, China)
Inhaled steroids as an intervention on long-term outcome of cough variant asthma M. Fujimura, H. Ogawa, K. Nishi (Kanazawa, Japan)
Evaluation of ocular complications of long-term inhaled steroid use E. F. Erkin, P. Celik, C. Guler, A. Yorgancioglu (Manisa, Turkey)
Equivalence of beclomethasone dipropionate (1000 μg/die) and budesonide (800 μg/die) in patients with moderate asthma on clinical findings and inflammatory markers A. Di Franco, D. Giannini, E. Bacci, I. Conti, L. Scuotri, M. Tonelli, B. Vagaggini, P. L. Paggiaro (Pisa, Italy)
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients M. I. Boskovska, D. Dokic, K. Busletic-Bozinovska, S. Arbutina, Z. Goseva (Skopje, Macedonia)
The effects of inhaled glucocorticoids on human neutrophil apoptosis X. Zhang, E. Moilanen, H. Kankaanranta (Tampere, Finland)
Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma O. P. Pashchenko, B. I. Geltser, T. N. Sourovenko, E. A. Kochetkova (Vladivostok, Russia)
Comparative clinical study of addition theophylline to low-dose inhaled beclomethasone dipropionate and medium-dose inhaled beclomethasone dipropionate in patients with mild-to-moderate persistent asthma S. S. Cekic, M. D. Filipovic, S. S. Pljaskic-Kamenov (Nis, Yugoslavia)